| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 03/14/2007 | EP1761532A1 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 03/14/2007 | EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same |
| 03/14/2007 | EP1244800B1 Rapamycin analogs |
| 03/14/2007 | EP1163240B1 Tricyclic benzoylpyrazole derivatives used as a herbicide |
| 03/14/2007 | CN1930170A Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| 03/14/2007 | CN1929836A (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
| 03/14/2007 | CN1927862A Garcinia acid derivatives, preparation method and application thereof in pharmacy |
| 03/14/2007 | CN1304005C Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound |
| 03/13/2007 | US7189851 Condensed heterocyclic compounds as calcitonin agonists |
| 03/13/2007 | US7189847 Levofloxicin prepared by reduction of an entantiomorph of 2,3,4 trihalo,N-(1-alkoxycarbonylethyl-)aniline by a metal borohydride in an aprotic solvent and alcohol; reacting the product with a 2,2-dialkoxycarbonyl-ethyl halide; cyclization using a base and phase transfer agents; optical purity;efficiency |
| 03/13/2007 | US7189736 Prodrugs of imidazopyridine derivatives |
| 03/13/2007 | US7189735 Use of CCI-779 as an antineoplastic agent |
| 03/13/2007 | US7189713 Piperidine derivatives |
| 03/08/2007 | WO2007027649A1 Method for synthesizing spiro quaternary ammonium systems |
| 03/08/2007 | WO2007025897A2 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 03/08/2007 | WO2006125178A3 Tricyclic pyridazine compounds and their uses as therapeutic agents |
| 03/08/2007 | US20070054946 Novel indeno[2,1A]indenes and isoindolo[2,1-A]indoles |
| 03/08/2007 | US20070054934 Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent |
| 03/08/2007 | US20070054881 Anxiolytic agents with reduced sedative and ataxic effects |
| 03/08/2007 | CA2620127A1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 03/07/2007 | EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/07/2007 | EP1758910A1 Substituted triazole derivatives as oxytocin antagonists |
| 03/07/2007 | EP1758899A1 Asymmetric michael and aldol addition using bifunctional cinchona-alkaloid-based catalysts |
| 03/07/2007 | EP1758453A2 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| 03/07/2007 | EP1461342B1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | CN1926143A Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |
| 03/07/2007 | CN1303085C C6- and C9-substituted isoxazoline derivatives and their use as anti-depressants |
| 03/07/2007 | CN1303084C New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 03/06/2007 | US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 03/06/2007 | US7186843 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186518 Method and composition useful for determining FK 506 |
| 03/06/2007 | CA2263480C Process for the preparation of n-[(1-nbutyl-4-piperidyl)methyl] -3,4-dihydro -2h-[1,3] oxazino[3,2-a] indole-10-carboxamide and salts and intermediates in the process |
| 03/01/2007 | WO2007025307A2 Inhibitors of serine proteases |
| 03/01/2007 | WO2007024835A2 Preparation of 2,6-dioxa-7-aza-bicyclo[2.2.2]octanes, and their use in coatings |
| 03/01/2007 | WO2007023382A2 Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
| 03/01/2007 | US20070049752 Preparation of 2,6-dioxa-7-aza-bicyclo[2.2.2] octanes |
| 03/01/2007 | US20070049603 Raf inhibitor compounds and methods of use thereof |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070049586 8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 03/01/2007 | US20070049580 Anxiolytic agents with reduced sedative and ataxic effects |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | CA2620621A1 Inhibitors of serine proteases |
| 02/28/2007 | EP1757610A1 Condensed pyrimidine derivative and xanthine oxidase inhibitor |
| 02/28/2007 | EP1757598A1 Substituted pyrrolidine derivative |
| 02/28/2007 | EP1756069A2 Hiv integrase inhibitors |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1756060A1 Therapeutic compounds: pyridine as scaffold |
| 02/28/2007 | EP1418912B1 Isoxazolopyridinones |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1921854A Heterocyclic GABAA subtype selective receptor modulators |
| 02/27/2007 | US7183412 Ester or amide derivatives |
| 02/27/2007 | US7183289 39-desmethoxyrapamycin, compositions and methods of use thereof |
| 02/22/2007 | WO2007022068A1 Olanzapine analogs and methods of use thereof |
| 02/22/2007 | WO2006068978A3 Dipeptidyl peptidase inhibitors |
| 02/22/2007 | WO2006059103A3 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 02/22/2007 | US20070043044 such as 2-Amino-4-phenyl-thieno[2,3-d]pyrimidine-6-carboxylic acid ethylamide; veterinary medicine; anticancer agents |
| 02/22/2007 | US20070043039 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 02/22/2007 | CA2617107A1 Olanzapine analogs and methods of use thereof |
| 02/21/2007 | EP1754482A1 Use of an ascomycin for the treatment of blepharitis |
| 02/21/2007 | EP1753748A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 02/21/2007 | EP1753463A2 Antibody drug conjugates and methods |
| 02/21/2007 | EP1753428A2 Kinase inhibitors as therapeutic agents |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | CN1918172A 利福霉素类似物及其用途 Rifamycin analogs and their use |
| 02/21/2007 | CN1918171A Chemokine ccr5 receptor modulators |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1915981A 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 02/20/2007 | US7179830 Such as 2-(4-methyl-3-thienylamino)-1H-thieno[3,4-d]imidazole for treatment of repiratory disorders, sleep apnea |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179805 Microbiocides; bactericides |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/15/2007 | WO2007019417A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019295A1 Methods of preparing quinolone analogs |
| 02/15/2007 | WO2007019191A2 Thiazolopyrimidine kinase inhibitors |
| 02/15/2007 | WO2007019078A2 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/15/2007 | WO2007018998A2 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 02/15/2007 | WO2007017828A2 Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 02/15/2007 | WO2007017029A1 Purification of tacrolimus on supports of vegetable origin |
| 02/15/2007 | WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 02/15/2007 | US20070037973 reacting a cyclic alpha , beta -unsaturated ketone compound with a nitroso compound in the presence of a proline-based catalyst to provide 7-Phenyl-6-oxa-7-aza-bicyclo[3.2.2]nonan-9-one or derivatives; catalytic asymmetric O-nitroso Aldol/Michael reaction |
| 02/15/2007 | US20070037842 Polymorphs and amorphous form of (s)-(+)-clopidogrel bisulfate |
| 02/15/2007 | US20070037809 histone deacetylase inhibitors, used for treating preventing diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood disorders, inflammation, cancer, and/or hot flashes |
| 02/15/2007 | US20070037798 Thiolactones |
| 02/15/2007 | US20070037791 serine/threonine kinase inhibitors, useful for therapy and/or prophylaxis of cancers in mammals |
| 02/15/2007 | CA2618370A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | CA2616977A1 Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 02/15/2007 | CA2616020A1 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 02/14/2007 | EP1751286A2 Biosynthetic gene cluster for the production of a complex polyketide |
| 02/14/2007 | EP1751168A1 Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase |
| 02/14/2007 | EP1751163A2 Compounds having affinity for dopamine d3 receptor and uses thereof |
| 02/14/2007 | EP1751130A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 02/14/2007 | EP0820283B1 Lactacystin analogs |
| 02/14/2007 | CN1914212A Polymorphic forms of a GABAA agonist |
| 02/14/2007 | CN1911933A Oxygen, nitrogen heterocyclic naphthoyl imine kind compound and its bioapplication |